rs147000290
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_024105.4(ALG12):c.1425G>C(p.Gln475His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,614,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Q475Q) has been classified as Likely benign.
Frequency
Consequence
NM_024105.4 missense
Scores
Clinical Significance
Conservation
Publications
- ALG12-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALG12 | NM_024105.4 | c.1425G>C | p.Gln475His | missense_variant | Exon 10 of 10 | ENST00000330817.11 | NP_077010.1 | |
| ALG12 | XM_017028936.2 | c.1238+299G>C | intron_variant | Intron 9 of 9 | XP_016884425.1 | |||
| ALG12 | XM_017028937.2 | c.1238+299G>C | intron_variant | Intron 9 of 10 | XP_016884426.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALG12 | ENST00000330817.11 | c.1425G>C | p.Gln475His | missense_variant | Exon 10 of 10 | 1 | NM_024105.4 | ENSP00000333813.5 | ||
| ENSG00000273192 | ENST00000610245.1 | n.1653C>G | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| ALG12 | ENST00000486602.1 | c.444-1G>C | splice_acceptor_variant, intron_variant | Intron 3 of 3 | 3 | ENSP00000420630.1 | ||||
| ALG12 | ENST00000492791.1 | n.*244G>C | downstream_gene_variant | 3 | ENSP00000417387.1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152264Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000994 AC: 25AN: 251430 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000335 AC: 51AN: 152382Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74516 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
- -
ALG12-congenital disorder of glycosylation Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 475 of the ALG12 protein (p.Gln475His). This variant is present in population databases (rs147000290, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ALG12-related conditions. ClinVar contains an entry for this variant (Variation ID: 376929). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at